According to a company press release, officials with the Food and Drug Administration (FDA) have approved Trelegy Ellipta, a once-daily, triple therapy, fluticasone furoate/umeclidinum/vilanterol (FF/UMEC/VI) for the long-term maintenance treatment of patients diagnosed with Chronic Obstructive Pulmonary Disease (COPD).

If you have COPD, then you know that getting sick can wreak havoc on your daily life. Even common illnesses like the cold or flu can significantly increase your COPD symptoms and, in serious cases, even land you in the hospital.

Getting enough sleep is a daily challenge for many people with COPD. Between coughing, breathing troubles, and shortness of breath, it's no wonder that the disease makes it difficult to relax and sleep soundly at night.

If you have COPD, you're probably no stranger to feeling drained, tired, and lethargic. Fatigue is a common problem for COPD patients, and a serious one at that. Fatigue is a common culprit behind exercise avoidance and sedentary living, which causes many patients to experience a quicker physical decline.

If you have COPD, then you know that it can be dangerous when your symptoms suddenly get worse. That's why preventing flare-ups and exacerbations is one of the main goals of treatment for people with COPD.

If you have COPD, you're probably especially concerned about making healthy diet and lifestyle choices. You have to maintain your health carefully to prevent the disease from progressing, and that means eating nutritious foods and avoiding unhealthy and toxic substances.

Many people with COPD also struggle with anxiety. It's an understandable reaction to the daily worries and hardships of living with a chronic disease. However, for patients who don't find ways to treat their anxiety and manage it in healthy ways, that anxiety can grow to the point that it causes serious problems and affects many aspects of their lives.

COPD is a life-long, chronic disease that can cause a great deal of stress, anxiety, and physical discomfort. Because of this, people with COPD often have to grapple with depression and other psychological issues as a result of living with this difficult disease.

"Is being barrel chested bad?" — In the later stages of COPD, some people with the disease begin to notice a barrel-shaped chest that, understandably, leads to concern. Although this is not always a serious issue, it can be a sign of emphysema, a type of COPD. 

As a respiratory disease, COPD comes with many symptoms, but the most serious and uncomfortable of these symptoms is difficulty breathing. These breathing problems have a variety of interconnected causes, including airway obstruction, reduced lung function, and a reduced capacity for exercise that are all caused by COPD.